Skip to main content
. Author manuscript; available in PMC: 2021 Jul 21.
Published in final edited form as: Inorg Chem. 2020 Jul 28;59(16):11715–11727. doi: 10.1021/acs.inorgchem.0c01629

Table 3.

Results from in vitro EDTA transchelation stability assays.*

Starting complex Ligand challenge pH % Intact starting species by incubation time
Initial 1 h 3 h 1 d 3 d 5 d 7 d
89Zr(DFO2) 100 fold excess EDTA 8.0 100 100 100 99.9 ± 0.1 94.3 ± 2.2 88.6 ± 2.8 81.4 ± 1.4
7.5 100 100 100 100 98.9 ± 1.0 97.6 ± 1.2 95.0 ± 0.5
7.0 100 100 100 99.8 ± 0.1 98.7 ± 0.3 92.5 ± 6.4 85.3 ± 2.7
6.5 100 100 99.5 ± 0.2 99.9 ± 0.2 98.0 ± 1.5 95.5 ± 1.9 90.4 ± 4.9
6 100 98.6 ± 0.4 96.6 ± 0.7 77.6 ± 2.9 42.1 ± 8.0 27.1 ± 8.1 20.6 ± 5.9
5.5 100 95.6 ± 1.0 90.2 ± 0.5 35.4 ± 1.1 7.0 ± 2.0 3.9 ± 1.8 1.5 ± 0.7
5.0 100 74.3 ± 0.9 43.9 ± 3.0 1.6 ± 0.1 1.0 ± 0.4 1.0 ± 0.6 0.6 ± 0.2
89Zr(DFO) 100 fold excess EDTA 8.0 98.1 ± 0.2 96.8 ± 1.3 97.5 ± 0.4 91.8 ± 1.3 75.9 ± 1.7 53.7 ± 1.4 33.6 ± 4.3
7.5 97.3 ± 0.6 96.6 ± 0.3 95.8 ± 0.5 84.9 ± 2.1 59.7 ± 5.5 36.5 ± 11.2 23.7 ± 9.6
7.0 96.2 ± 0.7 95.9 ± 0.7 95.5 ± 0.7 79.0 ± 1.6 50.2 ± 3.6 28.1 ± 8.1 16.1 ± 4.4
6.5 95.5 + 0.9 96.4 + 2.2 92.7 + 0.4 58.2 ± 3.6 21.6 + 1.5 11.6 + 0.7 8.5 + 1.4
6 99.3 + 0.2 94.9 + 0.2 84.6 + 2.2 20.4 ± 1.5 4.5 + 0.2 3.6 + 0.5 3.4 + 1.3
5.5 99.1 ± 0.2 89.6 ± 0.7 69.9 ± 1.5 5.3 ± 0.8 2.4 ± 0.3 2.7 ± 0.3 1.9 ± 0.1
5.0 97.0 ± 0.2 63.5 ± 1.3 27.3 ± 3.3 1.9 ± 0.7 1.1 ± 0.1 1.2 ± 0.1 1.1 + 0.0
100–99% 98–90% 89–80% ≤ 79%
*

Pre-radiolabeled [89Zr]Zr(DFO) and [89Zr]Zr(DFO2) complexes were mixed with a 100-fold molar excess of EDTA chelator at various pH values, and monitored by radio-iTLC for 7 days.